---
category: news
title: "Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism"
excerpt: "Wild type control and Fmr1 KO animals were treated with 0.1 mg/kg and 0.3 mg/kg oral psilocybin every other day for 6 treatments, over a 2-week period, and on day 18 underwent object recognition testing. We had great results! Both 0.1 and 0.3 mg/kg were ..."
publishedDateTime: 2022-02-16T12:00:00Z
originalUrl: "https://www.newswire.ca/news-releases/nova-mentis-study-confirms-oral-microdose-psilocybin-treatment-of-autism-874353648.html"
webUrl: "https://www.newswire.ca/news-releases/nova-mentis-study-confirms-oral-microdose-psilocybin-treatment-of-autism-874353648.html"
type: article
quality: 23
heat: 23
published: false

provider:
  name: Newswire
  domain: newswire.ca

topics:
  - Computer Vision
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1747767/NOVA_logo.jpg?p=facebook"
    width: 1000
    height: 524
    isCached: true

secured: "dRdl92zEy1BX5Fxrj7bj78ymh0oiMDKn6DEz0hlvGC/V+v3IzqMBnYbxFryLUjMTgIyv95f/oDRK6xBom28LhL4LaI5nFu/qChtoLRvQlOxuXPC9C2xbRua+DkCG4hY7j4+x+YP45WGPAmsDadT/bGRhGOC+T2yG1hmcpQ277cyee95dtrieY5JaxAdmYa4ydYtkhbofUPE7OlYCJkP4JtYU6hS/Ob2meyuM39ZDfGtfDlWQ9mB9wFTzPTfZprO8xLICgVOEUl14PT+Rkb0EdgwBuNn8+fRZ31bCn5RSVf16LXAGYTDQYacR/K0cSs7xjpXfVywoPiw7K/nWD6zr73Drj9Cc8ojdI5YE0cd8HMc=;biQ6B8LThyaV2YW77fTmqA=="
---

